(Q43804982)

27 November 2017

Continuing controversy over adjuvant therapy of pancreatic cancer (English)

1 reference

27 November 2017

R A Abrams

1

1 reference

27 November 2017

K D Lillemoe

series ordinal

2

1 reference

27 November 2017

S Piantadosi

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

358

1 reference

27 November 2017

9293

1 reference

27 November 2017

1565-1566

1 reference

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Adjuvant therapy for pancreatic cancer: back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906666-1

7 January 2021

10.1016/S0140-6736(01)06666-1

Identifiers

DOI

1 reference

27 November 2017

1 reference